Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026)
Catalyst Pharmaceuticals posted quarterly Current Taxes of $19.6 million for Q1 2026, up 77.02% year-on-year from $11.1 million in Q1 2025, and up 1305.87% on a QoQ basis from $1.4 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 4 years of Current Taxes data on file, last reported at $19.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 77.02% year-over-year to $19.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.6 million (up 77.02% YoY), and the FY2025 full-year result was $1.4 million, up 56.15% from the prior year.
- Current Taxes for Q1 2026 stood at $19.6 million, up from $1.4 million in the prior quarter.
- Across five years, Current Taxes topped out at $19.6 million in Q1 2026 and bottomed at $15000.0 in Q2 2024.
- The 4-year median for Current Taxes is $811500.0 (2023), against an average of $4.4 million.
- The widest annual swing landed in 2024, when Current Taxes grew 22.63%; it then surged 2826.67% in 2025.
- A 4-year view of Current Taxes shows it stood at $729000.0 in 2023, then advanced by 22.63% to $894000.0 in 2024, then jumped by 56.15% to $1.4 million in 2025, then surged by 1305.87% to $19.6 million in 2026.
- The last three Current Taxes figures came in at $19.6 million (Q1 2026), $1.4 million (Q4 2025), and $710000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 19.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.63 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 710,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 11.09 Mn |
| Dec 31, 2024 | 894,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | 729,000.00 |